Reduction of Pulmonary Edema by Short-Acting Local Anesthetics

Local anesthetics (LAs) possess a variety of effects that cannot be explained by the typical block of neuronal sodium channels. Antithrombotic effects of LAs are well known, but LAs also act as bactericides. Therefore, an investigation of the influence of LAs on the inflammatory response of the isol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Regional anesthesia and pain medicine 2006-05, Vol.31 (3), p.254-259
Hauptverfasser: Konrad, Christoph J., Schuepfer, Guido K., Neuburger, Michael, Schley, Marcus, Schmelz, Martin, Schmeck, Joachim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 259
container_issue 3
container_start_page 254
container_title Regional anesthesia and pain medicine
container_volume 31
creator Konrad, Christoph J.
Schuepfer, Guido K.
Neuburger, Michael
Schley, Marcus
Schmelz, Martin
Schmeck, Joachim
description Local anesthetics (LAs) possess a variety of effects that cannot be explained by the typical block of neuronal sodium channels. Antithrombotic effects of LAs are well known, but LAs also act as bactericides. Therefore, an investigation of the influence of LAs on the inflammatory response of the isolated rat lung (n = 78) to an N-formyl- l-leucin-methionyl- l-phenylalanine (FMLP) stimulus was performed. The experiments were performed on isolated and ventilated rat lungs perfused with cell-free and plasma-free buffer. LAs (lidocaine and mepivacaine) were injected in various concentrations before application and activation of human granulocytes by FMLP. Pulmonary arterial pressure (PAP) and lung weight gain were monitored continuously. LAs in final dosages from 10 −2 to 10 −7 mg/kg body weight (n = 6 each) were injected into the pulmonary artery before treatment with FMLP (10 −6 M) to induce pulmonary arterial hypertension. Perfusate samples were taken intermittently to determine thromboxane A 2 (TX A 2) and endothelin-1 concentrations. Microscopic analyses were performed to assess the degree of lung injury. Pretreatment with LAs significantly reduced the FMLP-induced PAP increase (treatment group v sham group: 0.5 to 5 mm Hg v 8 mm Hg; P < .05) and the release of endothelin-1 (2.4 v 5 fmol/mL). Histologic damage seen as acute granulocytic alveolitis was reduced by lidocaine and mepivacaine, even below clinically relevant concentrations. LA pretreatment reduces inflammatory reactions after FMLP stimulus.
doi_str_mv 10.1016/j.rapm.2006.01.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_205124735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1098733906000563</els_id><sourcerecordid>1049819021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-9c128ae009dc3e13d9a718418c4e189d7428e1408b86da3f4e995409465e7b7e3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRrFb_gAcJ3hNnsptkF0QopX5AQfHjvCS7U5vSZOsmEfrv3dKCN08zh-d9h3kYu0JIEDC_XSW-3DRJCpAngAkAP2JnmPE0lnmGx2EHJeOCczVi5123AgBZiPyUjTAvAFGlZ-z-jexg-tq1kVtEr8O6cW3pt9HMUlNG1TZ6Xzrfx5OAtF_R3JlyHU1a6vol9bXpLtjJolx3dHmYY_b5MPuYPsXzl8fn6WQeGy6xj5XBVJYEoKzhhNyqskApUBpBKJUtRCoJBchK5rbkC0FKZQKUyDMqqoL4mN3sezfefQ_hvF65wbfhpE4hw1QUPAtQuoeMd13naaE3vm7CNxpB74zpld4Z0ztjGlAHYyF0fWgeqobsX-SgKAB3e4DCfz81ed2ZmlpDtvZkem1d_V__L3-Meok</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205124735</pqid></control><display><type>article</type><title>Reduction of Pulmonary Edema by Short-Acting Local Anesthetics</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Konrad, Christoph J. ; Schuepfer, Guido K. ; Neuburger, Michael ; Schley, Marcus ; Schmelz, Martin ; Schmeck, Joachim</creator><creatorcontrib>Konrad, Christoph J. ; Schuepfer, Guido K. ; Neuburger, Michael ; Schley, Marcus ; Schmelz, Martin ; Schmeck, Joachim</creatorcontrib><description>Local anesthetics (LAs) possess a variety of effects that cannot be explained by the typical block of neuronal sodium channels. Antithrombotic effects of LAs are well known, but LAs also act as bactericides. Therefore, an investigation of the influence of LAs on the inflammatory response of the isolated rat lung (n = 78) to an N-formyl- l-leucin-methionyl- l-phenylalanine (FMLP) stimulus was performed. The experiments were performed on isolated and ventilated rat lungs perfused with cell-free and plasma-free buffer. LAs (lidocaine and mepivacaine) were injected in various concentrations before application and activation of human granulocytes by FMLP. Pulmonary arterial pressure (PAP) and lung weight gain were monitored continuously. LAs in final dosages from 10 −2 to 10 −7 mg/kg body weight (n = 6 each) were injected into the pulmonary artery before treatment with FMLP (10 −6 M) to induce pulmonary arterial hypertension. Perfusate samples were taken intermittently to determine thromboxane A 2 (TX A 2) and endothelin-1 concentrations. Microscopic analyses were performed to assess the degree of lung injury. Pretreatment with LAs significantly reduced the FMLP-induced PAP increase (treatment group v sham group: 0.5 to 5 mm Hg v 8 mm Hg; P &lt; .05) and the release of endothelin-1 (2.4 v 5 fmol/mL). Histologic damage seen as acute granulocytic alveolitis was reduced by lidocaine and mepivacaine, even below clinically relevant concentrations. LA pretreatment reduces inflammatory reactions after FMLP stimulus.</description><identifier>ISSN: 1098-7339</identifier><identifier>EISSN: 1532-8651</identifier><identifier>DOI: 10.1016/j.rapm.2006.01.003</identifier><identifier>PMID: 16701192</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Anesthetics, Local - pharmacology ; Anesthetics, Local - therapeutic use ; Animals ; Blood Pressure ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Endothelin ; FMLP ; Granulocytes - drug effects ; Granulocytes - pathology ; In Vitro Techniques ; Lidocaine - pharmacology ; Lidocaine - therapeutic use ; Local anesthetics ; Lung ; Lung - blood supply ; Lung - drug effects ; Lung - pathology ; Mepivacaine - pharmacology ; Mepivacaine - therapeutic use ; N-Formylmethionine Leucyl-Phenylalanine ; Organ Size ; Pneumonia - chemically induced ; Pneumonia - drug therapy ; Pneumonia - pathology ; Pulmonary Artery - drug effects ; Pulmonary Artery - physiopathology ; Pulmonary Edema - chemically induced ; Pulmonary Edema - drug therapy ; Pulmonary Edema - pathology ; Rats ; Rats, Sprague-Dawley ; Regional anesthesia ; Time Factors</subject><ispartof>Regional anesthesia and pain medicine, 2006-05, Vol.31 (3), p.254-259</ispartof><rights>2006 American Society of Regional Anesthesia and Pain Medicine</rights><rights>Copyright Churchill Livingstone Inc., Medical Publishers May/Jun 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-9c128ae009dc3e13d9a718418c4e189d7428e1408b86da3f4e995409465e7b7e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16701192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Konrad, Christoph J.</creatorcontrib><creatorcontrib>Schuepfer, Guido K.</creatorcontrib><creatorcontrib>Neuburger, Michael</creatorcontrib><creatorcontrib>Schley, Marcus</creatorcontrib><creatorcontrib>Schmelz, Martin</creatorcontrib><creatorcontrib>Schmeck, Joachim</creatorcontrib><title>Reduction of Pulmonary Edema by Short-Acting Local Anesthetics</title><title>Regional anesthesia and pain medicine</title><addtitle>Reg Anesth Pain Med</addtitle><description>Local anesthetics (LAs) possess a variety of effects that cannot be explained by the typical block of neuronal sodium channels. Antithrombotic effects of LAs are well known, but LAs also act as bactericides. Therefore, an investigation of the influence of LAs on the inflammatory response of the isolated rat lung (n = 78) to an N-formyl- l-leucin-methionyl- l-phenylalanine (FMLP) stimulus was performed. The experiments were performed on isolated and ventilated rat lungs perfused with cell-free and plasma-free buffer. LAs (lidocaine and mepivacaine) were injected in various concentrations before application and activation of human granulocytes by FMLP. Pulmonary arterial pressure (PAP) and lung weight gain were monitored continuously. LAs in final dosages from 10 −2 to 10 −7 mg/kg body weight (n = 6 each) were injected into the pulmonary artery before treatment with FMLP (10 −6 M) to induce pulmonary arterial hypertension. Perfusate samples were taken intermittently to determine thromboxane A 2 (TX A 2) and endothelin-1 concentrations. Microscopic analyses were performed to assess the degree of lung injury. Pretreatment with LAs significantly reduced the FMLP-induced PAP increase (treatment group v sham group: 0.5 to 5 mm Hg v 8 mm Hg; P &lt; .05) and the release of endothelin-1 (2.4 v 5 fmol/mL). Histologic damage seen as acute granulocytic alveolitis was reduced by lidocaine and mepivacaine, even below clinically relevant concentrations. LA pretreatment reduces inflammatory reactions after FMLP stimulus.</description><subject>Anesthetics, Local - pharmacology</subject><subject>Anesthetics, Local - therapeutic use</subject><subject>Animals</subject><subject>Blood Pressure</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Endothelin</subject><subject>FMLP</subject><subject>Granulocytes - drug effects</subject><subject>Granulocytes - pathology</subject><subject>In Vitro Techniques</subject><subject>Lidocaine - pharmacology</subject><subject>Lidocaine - therapeutic use</subject><subject>Local anesthetics</subject><subject>Lung</subject><subject>Lung - blood supply</subject><subject>Lung - drug effects</subject><subject>Lung - pathology</subject><subject>Mepivacaine - pharmacology</subject><subject>Mepivacaine - therapeutic use</subject><subject>N-Formylmethionine Leucyl-Phenylalanine</subject><subject>Organ Size</subject><subject>Pneumonia - chemically induced</subject><subject>Pneumonia - drug therapy</subject><subject>Pneumonia - pathology</subject><subject>Pulmonary Artery - drug effects</subject><subject>Pulmonary Artery - physiopathology</subject><subject>Pulmonary Edema - chemically induced</subject><subject>Pulmonary Edema - drug therapy</subject><subject>Pulmonary Edema - pathology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Regional anesthesia</subject><subject>Time Factors</subject><issn>1098-7339</issn><issn>1532-8651</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kE1Lw0AQhhdRrFb_gAcJ3hNnsptkF0QopX5AQfHjvCS7U5vSZOsmEfrv3dKCN08zh-d9h3kYu0JIEDC_XSW-3DRJCpAngAkAP2JnmPE0lnmGx2EHJeOCczVi5123AgBZiPyUjTAvAFGlZ-z-jexg-tq1kVtEr8O6cW3pt9HMUlNG1TZ6Xzrfx5OAtF_R3JlyHU1a6vol9bXpLtjJolx3dHmYY_b5MPuYPsXzl8fn6WQeGy6xj5XBVJYEoKzhhNyqskApUBpBKJUtRCoJBchK5rbkC0FKZQKUyDMqqoL4mN3sezfefQ_hvF65wbfhpE4hw1QUPAtQuoeMd13naaE3vm7CNxpB74zpld4Z0ztjGlAHYyF0fWgeqobsX-SgKAB3e4DCfz81ed2ZmlpDtvZkem1d_V__L3-Meok</recordid><startdate>20060501</startdate><enddate>20060501</enddate><creator>Konrad, Christoph J.</creator><creator>Schuepfer, Guido K.</creator><creator>Neuburger, Michael</creator><creator>Schley, Marcus</creator><creator>Schmelz, Martin</creator><creator>Schmeck, Joachim</creator><general>Elsevier Inc</general><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20060501</creationdate><title>Reduction of Pulmonary Edema by Short-Acting Local Anesthetics</title><author>Konrad, Christoph J. ; Schuepfer, Guido K. ; Neuburger, Michael ; Schley, Marcus ; Schmelz, Martin ; Schmeck, Joachim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-9c128ae009dc3e13d9a718418c4e189d7428e1408b86da3f4e995409465e7b7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Anesthetics, Local - pharmacology</topic><topic>Anesthetics, Local - therapeutic use</topic><topic>Animals</topic><topic>Blood Pressure</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Endothelin</topic><topic>FMLP</topic><topic>Granulocytes - drug effects</topic><topic>Granulocytes - pathology</topic><topic>In Vitro Techniques</topic><topic>Lidocaine - pharmacology</topic><topic>Lidocaine - therapeutic use</topic><topic>Local anesthetics</topic><topic>Lung</topic><topic>Lung - blood supply</topic><topic>Lung - drug effects</topic><topic>Lung - pathology</topic><topic>Mepivacaine - pharmacology</topic><topic>Mepivacaine - therapeutic use</topic><topic>N-Formylmethionine Leucyl-Phenylalanine</topic><topic>Organ Size</topic><topic>Pneumonia - chemically induced</topic><topic>Pneumonia - drug therapy</topic><topic>Pneumonia - pathology</topic><topic>Pulmonary Artery - drug effects</topic><topic>Pulmonary Artery - physiopathology</topic><topic>Pulmonary Edema - chemically induced</topic><topic>Pulmonary Edema - drug therapy</topic><topic>Pulmonary Edema - pathology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Regional anesthesia</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Konrad, Christoph J.</creatorcontrib><creatorcontrib>Schuepfer, Guido K.</creatorcontrib><creatorcontrib>Neuburger, Michael</creatorcontrib><creatorcontrib>Schley, Marcus</creatorcontrib><creatorcontrib>Schmelz, Martin</creatorcontrib><creatorcontrib>Schmeck, Joachim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Regional anesthesia and pain medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Konrad, Christoph J.</au><au>Schuepfer, Guido K.</au><au>Neuburger, Michael</au><au>Schley, Marcus</au><au>Schmelz, Martin</au><au>Schmeck, Joachim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction of Pulmonary Edema by Short-Acting Local Anesthetics</atitle><jtitle>Regional anesthesia and pain medicine</jtitle><addtitle>Reg Anesth Pain Med</addtitle><date>2006-05-01</date><risdate>2006</risdate><volume>31</volume><issue>3</issue><spage>254</spage><epage>259</epage><pages>254-259</pages><issn>1098-7339</issn><eissn>1532-8651</eissn><abstract>Local anesthetics (LAs) possess a variety of effects that cannot be explained by the typical block of neuronal sodium channels. Antithrombotic effects of LAs are well known, but LAs also act as bactericides. Therefore, an investigation of the influence of LAs on the inflammatory response of the isolated rat lung (n = 78) to an N-formyl- l-leucin-methionyl- l-phenylalanine (FMLP) stimulus was performed. The experiments were performed on isolated and ventilated rat lungs perfused with cell-free and plasma-free buffer. LAs (lidocaine and mepivacaine) were injected in various concentrations before application and activation of human granulocytes by FMLP. Pulmonary arterial pressure (PAP) and lung weight gain were monitored continuously. LAs in final dosages from 10 −2 to 10 −7 mg/kg body weight (n = 6 each) were injected into the pulmonary artery before treatment with FMLP (10 −6 M) to induce pulmonary arterial hypertension. Perfusate samples were taken intermittently to determine thromboxane A 2 (TX A 2) and endothelin-1 concentrations. Microscopic analyses were performed to assess the degree of lung injury. Pretreatment with LAs significantly reduced the FMLP-induced PAP increase (treatment group v sham group: 0.5 to 5 mm Hg v 8 mm Hg; P &lt; .05) and the release of endothelin-1 (2.4 v 5 fmol/mL). Histologic damage seen as acute granulocytic alveolitis was reduced by lidocaine and mepivacaine, even below clinically relevant concentrations. LA pretreatment reduces inflammatory reactions after FMLP stimulus.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>16701192</pmid><doi>10.1016/j.rapm.2006.01.003</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1098-7339
ispartof Regional anesthesia and pain medicine, 2006-05, Vol.31 (3), p.254-259
issn 1098-7339
1532-8651
language eng
recordid cdi_proquest_journals_205124735
source MEDLINE; Journals@Ovid Complete
subjects Anesthetics, Local - pharmacology
Anesthetics, Local - therapeutic use
Animals
Blood Pressure
Disease Models, Animal
Dose-Response Relationship, Drug
Endothelin
FMLP
Granulocytes - drug effects
Granulocytes - pathology
In Vitro Techniques
Lidocaine - pharmacology
Lidocaine - therapeutic use
Local anesthetics
Lung
Lung - blood supply
Lung - drug effects
Lung - pathology
Mepivacaine - pharmacology
Mepivacaine - therapeutic use
N-Formylmethionine Leucyl-Phenylalanine
Organ Size
Pneumonia - chemically induced
Pneumonia - drug therapy
Pneumonia - pathology
Pulmonary Artery - drug effects
Pulmonary Artery - physiopathology
Pulmonary Edema - chemically induced
Pulmonary Edema - drug therapy
Pulmonary Edema - pathology
Rats
Rats, Sprague-Dawley
Regional anesthesia
Time Factors
title Reduction of Pulmonary Edema by Short-Acting Local Anesthetics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A04%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20of%20Pulmonary%20Edema%20by%20Short-Acting%20Local%20Anesthetics&rft.jtitle=Regional%20anesthesia%20and%20pain%20medicine&rft.au=Konrad,%20Christoph%20J.&rft.date=2006-05-01&rft.volume=31&rft.issue=3&rft.spage=254&rft.epage=259&rft.pages=254-259&rft.issn=1098-7339&rft.eissn=1532-8651&rft_id=info:doi/10.1016/j.rapm.2006.01.003&rft_dat=%3Cproquest_cross%3E1049819021%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205124735&rft_id=info:pmid/16701192&rft_els_id=S1098733906000563&rfr_iscdi=true